1. Home
  2. RVMD vs MGM Comparison

RVMD vs MGM Comparison

Compare RVMD & MGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • MGM
  • Stock Information
  • Founded
  • RVMD 2014
  • MGM 1986
  • Country
  • RVMD United States
  • MGM United States
  • Employees
  • RVMD N/A
  • MGM N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • MGM Hotels/Resorts
  • Sector
  • RVMD Health Care
  • MGM Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • MGM Nasdaq
  • Market Cap
  • RVMD 8.7B
  • MGM 9.3B
  • IPO Year
  • RVMD 2020
  • MGM N/A
  • Fundamental
  • Price
  • RVMD $37.29
  • MGM $30.37
  • Analyst Decision
  • RVMD Strong Buy
  • MGM Strong Buy
  • Analyst Count
  • RVMD 13
  • MGM 16
  • Target Price
  • RVMD $67.77
  • MGM $51.06
  • AVG Volume (30 Days)
  • RVMD 1.3M
  • MGM 5.8M
  • Earning Date
  • RVMD 05-07-2025
  • MGM 04-30-2025
  • Dividend Yield
  • RVMD N/A
  • MGM N/A
  • EPS Growth
  • RVMD N/A
  • MGM N/A
  • EPS
  • RVMD N/A
  • MGM 2.40
  • Revenue
  • RVMD N/A
  • MGM $17,240,545,000.00
  • Revenue This Year
  • RVMD N/A
  • MGM $1.44
  • Revenue Next Year
  • RVMD $153.09
  • MGM $1.79
  • P/E Ratio
  • RVMD N/A
  • MGM $12.65
  • Revenue Growth
  • RVMD N/A
  • MGM 6.66
  • 52 Week Low
  • RVMD $29.55
  • MGM $29.99
  • 52 Week High
  • RVMD $62.40
  • MGM $48.25
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 42.92
  • MGM 37.28
  • Support Level
  • RVMD $37.42
  • MGM $31.16
  • Resistance Level
  • RVMD $39.59
  • MGM $32.41
  • Average True Range (ATR)
  • RVMD 1.32
  • MGM 1.00
  • MACD
  • RVMD 0.05
  • MGM -0.00
  • Stochastic Oscillator
  • RVMD 29.10
  • MGM 11.43

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About MGM MGM Resorts International

MGM Resorts is the largest resort operator on the Las Vegas Strip with 37,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 59% of total EBITDAR in 2024. MGM also owns US regional assets, which represented a low 20s share of 2024 EBITDAR (MGM's Macao EBITDAR was 21% of the total in 2024). MGM's US sports and i-gaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. We estimate MGM will open a resort in Japan in 2030.

Share on Social Networks: